DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹82.68 | ₹60.38 | ₹68.83 | ₹111.53 | ₹74.75 |
What is the latest Earnings Per Share (EPS) of DIVIS LABORATORIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹82.68 |
| Mar2025 | ₹60.38 |
| Mar2024 | ₹68.83 |
| Mar2023 | ₹111.53 |
| Mar2022 | ₹74.75 |
How is Earnings Per Share (EPS) of DIVIS LABORATORIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹82.68 | 36.93 | |
| Mar2025 | ₹60.38 | -12.28 | |
| Mar2024 | ₹68.83 | -38.29 | |
| Mar2023 | ₹111.53 | 49.20 | |
| Mar2022 | ₹74.75 | - | |
Compare Earnings Per Share (EPS) of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹293,908.5 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
| MANKIND PHARMA | ₹109,040.0 Cr | 0.2% | 17.2% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.3% |
21.8% |
68.7% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses